» Articles » PMID: 26074979

Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease: A Systematic Review of Animal Studies and Human Clinical Trials

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2015 Jun 16
PMID 26074979
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Low back pain and degenerative disc disease are a significant cause of pain and disability worldwide. Advances in regenerative medicine and cell-based therapies, particularly the transplantation of mesenchymal stem cells and intervertebral disc chondrocytes, have led to the publication of numerous studies and clinical trials utilising these biological therapies to treat degenerative spinal conditions, often reporting favourable outcomes. Stem cell mediated disc regeneration may bridge the gap between the two current alternatives for patients with low back pain, often inadequate pain management at one end and invasive surgery at the other. Through cartilage formation and disc regeneration or via modification of pain pathways stem cells are well suited to enhance spinal surgery practice. This paper will systematically review the current status of basic science studies, preclinical and clinical trials utilising cell-based therapies to repair the degenerate intervertebral disc. The mechanism of action of transplanted cells, as well as the limitations of published studies, will be discussed.

Citing Articles

High impact works on stem cell transplantation in intervertebral disc degeneration.

Chen X, Li H, Huang B, Ruan J, Li X, Li Q BMC Musculoskelet Disord. 2024; 25(1):1029.

PMID: 39702055 PMC: 11660786. DOI: 10.1186/s12891-024-08131-4.


Transplantation of active nucleus pulposus cells with a keep-charging hydrogel microsphere system to rescue intervertebral disc degeneration.

Tang Y, Zhang K, Zhou H, Zhang C, Liu Z, Chen H J Nanobiotechnology. 2023; 21(1):453.

PMID: 38017517 PMC: 10683266. DOI: 10.1186/s12951-023-02226-1.


Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential.

Munda M, Velnar T Biomol Biomed. 2023; 24(2):210-218.

PMID: 37669102 PMC: 10950333. DOI: 10.17305/bb.2023.9518.


Macrophage-based therapy for intervertebral disc herniation: preclinical proof-of-concept.

Ribeiro-Machado C, Santos S, Amaral I, Caldeira J, Pereira P, Barbosa M NPJ Regen Med. 2023; 8(1):34.

PMID: 37429889 PMC: 10333363. DOI: 10.1038/s41536-023-00309-z.


Mesenchymal stem cells can improve discogenic pain in patients with intervertebral disc degeneration: a systematic review and meta-analysis.

Zhang W, Wang D, Li H, Xu G, Zhang H, Xu C Front Bioeng Biotechnol. 2023; 11:1155357.

PMID: 37397969 PMC: 10313064. DOI: 10.3389/fbioe.2023.1155357.


References
1.
Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

2.
Prologo J, Pirasteh A, Tenley N, Yuan L, Corn D, Hart D . Percutaneous image-guided delivery for the transplantation of mesenchymal stem cells in the setting of degenerated intervertebral discs. J Vasc Interv Radiol. 2012; 23(8):1084-1088.e6. DOI: 10.1016/j.jvir.2012.04.032. View

3.
Sakaguchi Y, Sekiya I, Yagishita K, Muneta T . Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005; 52(8):2521-9. DOI: 10.1002/art.21212. View

4.
Ganey T, Libera J, Moos V, Alasevic O, Fritsch K, Meisel H . Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc. Spine (Phila Pa 1976). 2003; 28(23):2609-20. DOI: 10.1097/01.BRS.0000097891.63063.78. View

5.
ZuK P, Zhu M, Ashjian P, De Ugarte D, Huang J, Mizuno H . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13(12):4279-95. PMC: 138633. DOI: 10.1091/mbc.e02-02-0105. View